ADCs and Novel Drug Conjugates in Asia Report
Dive into an insightful analysis of the ADC commercial landscape in Asia. Curated by our expert Beacon Research Team, this report unveils invaluable competitive intelligence that will fuel your strategic decision-making.
What’s inside the report?
- Insights into the Asian ADC market over the past 10 years.
- Detailed company profiles of key players such as Lego Chem Biosciences and MediLink Therapeutics.
- The top 10 drug conjugate deals of 2023.
- An exploration of the prevalent drug targets shaping the landscape.
- An overview of deal types, highlighting the shift observed between 2022 and 2023.
- Insights into financing trends across various drug modalities.
You May Also Be Interested In…
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
